SA

Sumit Aggarwal

Active Director Director DIN 08941867
DIN 08941867 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Sumit Aggarwal

Data last updated:

Sumit Aggarwal is a Director at Mbs Lifescience Private Limited (since 2020). The company operates in Pharma. Mbs Lifescience Private Limited reported revenue of ₹183 Cr (FY 2025).

DIN 08941867
Primary Designation Director
Industry Pharma
First Appointment 30 Oct 2020
Oldest Company Age 6 yrs
Largest company Mbs Lifescience Private Limited · ₹183 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mbs Lifescience Private Limited U33119HP2020PTC008181
Director30 Oct 20202020₹183 Cr (FY 2025)Active

Board colleagues of Sumit Aggarwal

NameDINCompanyDesignation
Akash Gupta08941868Mbs Lifescience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mbs Lifescience Private Limited
Premium access

Shareholding and investment profile for Sumit Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Aggarwal

Sumit Aggarwal currently holds 1 directorship: Mbs Lifescience Private Limited (Director, since 30 Oct 2020, revenue ₹183 Cr (FY 2025)).

Sumit Aggarwal was first appointed on 30 Oct 2020 as Director at Mbs Lifescience Private Limited.

The current boards of Sumit Aggarwal's companies include Akash Gupta (Mbs Lifescience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available